COVID-19 has sickened tens of millions of people around the world and disrupted the global economy in a way never seen before. This pandemic once again reminds us of how devastating a virus outbreak can be. There is an urgent need for the research community to further our understanding of pathogenic viruses.
It's Sino Biological's long-standing mission to support infectious disease research. Earlier this year, the company launched the world's largest recombinant viral antigen collection, ProVirTM, containing over 800 viral antigens from 350+ strains. These antigens are of particular interest to investigators, as they can be good biomarkers for diagnostics and targets for therapies.